Patent · US Active

Transdermal hormone replacement therapies

US9248136B2 · kind B2 · utility

40Cited by

557References

20Claims

0Family size

Assignee

Compass Therapeutics LLC · US

Inventors

Brian A. Bernick · Boca Raton, US
Julia M. Amadio · Boca Raton, US
Peter H. R. Persicaner · Boca Raton, US
Janice Louise Cacace · St. Petersburg, US
Neda Irani · North Palm Beach, US
Frederick D. Sancilio · North Palm Beach, US

Key dates

Filing date	Jan 25, 2013
Grant date	Feb 2, 2016
Priority date	—
Expiry date	Jan 25, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via transdermal HRT delivery systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.